SAKURABONSAI: CLINICAL, IMAGING AND BIOMARKER OPEN-LABEL STUDY IN NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) WITH SATRALIZUMAB AS AN INTERVENTION

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Brain Imaging Center (BIC)
University of Colorado Hospital

Study ID

Protocol Number: 21-4079

More information available at ClinicalTrials.gov: NCT05269667

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers